Results 101 to 110 of about 659,276 (230)

Use of Sodium‐Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi‐Database and Cross‐Country Study in Patients With Type 2 Diabetes Mellitus

Clinical Pharmacology &Therapeutics, Volume 117, Issue 6, Page 1775-1783, June 2025.
The benefits of sodium‐glucose transport protein 2 inhibitor (SGLT2i) use on severe urolithiasis requiring surgery remains unclear. All patients with incident T2D in Taiwan National Health Institution databases (2016–2021) and TriNetX datasets (2014–2023) were retrospectively analyzed.
Mu‐Chi Chung, Chia‐Yen Lin, Chao‐Hsiang Chang, Yi‐Huei Chang, Po‐Jen Hsiao, Chi‐Shun Lien, Laing‐You Wu, Ming‐Ju Wu, Jeng‐Jer Shieh, Peir‐Haur Hung, Hsin‐Hua Chen, Chi‐Jung Chung   +11 more
wiley   +1 more source

Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report [PDF]

, 2013
BACKGROUND: Treatment with the alpha-glucosidase inhibitor (AGI) acarbose is associated with a significant reduction the risk of cardiovascular events. However, the underlying mechanisms of this effect are unclear.
Bao-cheng Chang, Chun-yan Shan, Hong-tao Zhou, Hui-zhu Ren, Ju-hong Yang, Li-ming Chen, Miao-yan Zheng, Yan-guang Xu, Ying Wang   +8 more
core   +1 more source

Cutaneous side effects of diabetes treatment [PDF]

, 2016
As lesões cutâneas são frequentes na diabetes mellitus, havendo um envolvimento da pele em cerca de 30 a 91% dos doentes durante o curso da doença. Estas podem ser não infeciosas ou autoimunes, infeciosas ou resultar de complicações do tratamento da ...
Borges-Costa, J, Gomes, F
core  

Transaminase triggered aza-Michael approach for the enantioselective synthesis of piperidine scaffolds [PDF]

, 2016
The expanding “toolbox” of biocatalysts opens new opportunities to redesign synthetic strategies to target molecules by incorporating a key enzymatic step into the synthesis.
Andrew Gomm, Beatriz Maciá, Elaine O’Reilly, James Ryan, Mindaugas Šiaučiulis, Stewart J., Vittorio Caprio   +6 more
core   +3 more sources

Effects of dapagliflozin on podocyte damage and oxidative stress in patients with diabetic nephropathy

Diabetology & Metabolic Syndrome
Objective This study explores the effect of dapagliflozin treatment on podocyte injury and oxidative stress in patients with early diabetic nephropathy (T2DN). Methods: Clinical data from 78 patients with early T2DN, admitted to our hospital between June
Yajing Shi, Jingjing Zhang, Xiaoxiao Xin, Lixia Liu, Yaru Wu, Yanli Cheng, Li Zhang, Hong Su, Yuebin Zhao   +8 more
doaj   +1 more source

Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice [PDF]

, 2021
Cayasso, Mayella, László, F. János, Pórszász, Róbert, Szalai, Andrea, Ujhelyi, Judit Ágnes, Ujhelyi, Zoltán, Vecsernyés, Miklós   +6 more
core   +1 more source

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Comparative Study of Beta Cyclodextrin and Calix-8-Arene as Ionophores in Potentiometric Ion-Selective Electrodes for Sitagliptin Phosphate [PDF]

, 2012
El-Kosasy
openalex   +1 more source

Determination of sitagliptin phosphate in rat plasma by ultra high performance liquid chromatography-tandem mass spectrometry [PDF]

, 2011
Tang Yao, Xiang Li, Wen Nie, Xu Sun, Ling Zhu, Min Yu, LI Zuo-gang, Bo Li   +7 more
openalex   +1 more source

FORMULATION AND EVALUATION OF SITAGLIPTIN PHOSPHATE LOADED ORAL POLYMERIC FLOATING MICROBEADS

, 2021
B. Singha
openalex   +2 more sources